Conditional Relative Survival in Primary Central Nervous System Lymphoma: a Population-based Study in the Netherlands
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Janssen-Heijnen M, Gondos A, Bray F, Hakulinen T, Brewster D, Brenner H
. Clinical relevance of conditional survival of cancer patients in europe: age-specific analyses of 13 cancers. J Clin Oncol. 2010; 28(15):2520-8.
DOI: 10.1200/JCO.2009.25.9697.
View
2.
van der Meulen M, Dinmohamed A, Visser O, Doorduijn J, Bromberg J
. Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989-2015. Leukemia. 2017; 31(8):1822-1825.
DOI: 10.1038/leu.2017.128.
View
3.
Dickman P, Adami H
. Interpreting trends in cancer patient survival. J Intern Med. 2006; 260(2):103-17.
DOI: 10.1111/j.1365-2796.2006.01677.x.
View
4.
Mendez J, Ostrom Q, Gittleman H, Kruchko C, DeAngelis L, Barnholtz-Sloan J
. The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades. Neuro Oncol. 2017; 20(5):687-694.
PMC: 5892148.
DOI: 10.1093/neuonc/nox187.
View
5.
van der Meulen M, Bromberg J, Nijland M, Visser O, Doorduijn J, Dinmohamed A
. Primary therapy and survival in patients aged over 70-years-old with primary central nervous system lymphoma: a contemporary, nationwide, population-based study in the Netherlands. Haematologica. 2020; 106(2):597-600.
PMC: 7849552.
DOI: 10.3324/haematol.2020.247536.
View